LP
Leerink Partners Latest Price Targets & Analyst Ratings
# | Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|---|
1 |
1
Arcturus Therapeutics
ARCT
$455M
|
LN
Lili Nsongo
| $16.76 | $54 |
222%
upside
| Outperform | 13 days ago |
|
2 |
2
Moderna
MRNA
$9.45B
|
MF
Mani Foroohar
| $24.28 | $15 |
38%
downside
| Underperform | 13 days ago |
|
3 |
3
Premier
PINC
$2.17B
|
MC
Michael Cherny
| $26.28 | $26 |
1%
downside
| Market Perform | 16 days ago |
|
4 |
4
Xeris Biopharma Holdings
XERS
$1.27B
|
RR
Roanna Ruiz
| $7.89 | $9 |
14%
upside
| Outperform | 16 days ago |
|
5 |
5
Inspire Medical Systems
INSP
$2.55B
|
MK
Mike Kratky
| $86.32 | $97 |
12%
upside
| Market Perform | 20 days ago |
|
6 |
6
Cardinal Health
CAH
$35.7B
|
MC
Michael Cherny
| $149.34 | $186 |
25%
upside
| Outperform | 23 days ago |
|
7 |
7
Biohaven
BHVN
$1.7B
|
MG
Marc Goodman
| $16.07 | $50 |
211%
upside
| Outperform | 23 days ago |
|
8 |
8
CryoPort
CYRX
$443M
|
PS
Puneet Souda
| $8.85 | $16 |
81%
upside
| Outperform | 29 days ago |
|
9 |
9
Celcuity
CELC
$2.31B
|
AB
Andrew Berens
| $54.47 | $60 |
10%
upside
| Outperform | 1 month ago |
|
10 |
10
Replimune Group
REPL
$454M
|
JC
Jonathan Chang
| $5.81 | $3 |
48%
downside
| Market Perform | 1 month ago |
|
11 |
11
Elevance Health
ELV
$69.4B
|
WM
Whit Mayo
| $308.05 | $310 |
1%
upside
| Market Perform | 1 month ago |
|
12 |
12
Idexx Laboratories
IDXX
$51.2B
|
DC
Daniel Clark
| $640.44 | $600 |
6%
downside
| Outperform | 1 month ago |
|
13 |
13
Zoetis
ZTS
$67.9B
|
DC
Daniel Clark
| $153.20 | $155 |
1%
upside
| Market Perform | 1 month ago |
|
14 |
14
Elanco Animal Health
ELAN
$8.68B
|
DC
Daniel Clark
| $17.47 | $18 |
3%
upside
| Outperform | 1 month ago |
|
15 |
15
Rhythm Pharmaceuticals
RYTM
$6.95B
|
FK
Faisal Khurshid
| $104.57 | $102 |
2%
downside
| Outperform | 1 month ago |
|
16 |
16
Progyny
PGNY
$2.03B
|
MC
Michael Cherny
| $23.56 | $28 |
19%
upside
| Outperform | 1 month ago |
|
17 |
17
KalVista Pharmaceuticals
KALV
$765M
|
JS
Joseph Schwartz
| $15.20 | $20 |
32%
upside
| Outperform | 1 month ago |
|
18 |
18
Cogent Biosciences
COGT
$1.81B
|
AB
Andrew Berens
| $12.94 | $18 |
39%
upside
| Outperform | 1 month ago |
|
19 |
19
AbCellera Biologics
ABCL
$1.24B
|
FK
Faisal Khurshid
| $4.16 | $5 |
20%
upside
| Outperform | 1 month ago |
|
20 |
20
Zai Lab
ZLAB
$3.34B
|
JC
Jonathan Chang
| $30 | $75 |
150%
upside
| Outperform | 2 months ago |
|
21 |
21
Nuvalent
NUVL
$5.74B
|
AB
Andrew Berens
| $79.67 | $140 |
76%
upside
| Outperform | 2 months ago |
|
22 |
22
Boston Scientific
BSX
$159B
|
MK
Mike Kratky
| $107.29 | $118 |
10%
upside
| Outperform | 2 months ago |
|
23 |
23
Medtronic
MDT
$119B
|
MK
Mike Kratky
| $92.85 | $110 |
18%
upside
| Outperform | 2 months ago |
|
24 |
24
Summit Therapeutics
SMMT
$17.7B
|
DG
Daina Graybosch
| $23.80 | $12 |
50%
downside
| Underperform | 2 months ago |
|
25 |
25
Insmed
INSM
$30.1B
|
JS
Joseph Schwartz
| $142.53 | $115 |
19%
downside
| Outperform | 2 months ago |
|